These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3257514)

  • 1. T6 positive cells in the peripheral blood of burn patients: are they Langerhans cells precursors?
    Gothelf Y; Hanau D; Tsur H; Sharon N; Sahar E; Cazenave JP; Gazit E
    J Invest Dermatol; 1988 Feb; 90(2):142-8. PubMed ID: 3257514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization by receptor-mediated endocytosis of T6 (CD1 "NA1/34") surface antigen in T6 positive human cord blood cells (Langerhans cell precursors?).
    Hanau D; Gothelf Y; Schmitt DA; Fabre M; Garaud JC; Gazit E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1987; 29(5):279-83. PubMed ID: 3501858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 production by T6 (CD1a) positive cord blood mononuclear cells (Langerhan's cell precursors?).
    Gothelf Y; Dinarello CA; Yamin M; Sharon N; Milner Y; Gazit E
    Lymphokine Res; 1989; 8(4):373-82. PubMed ID: 2478842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subset of human cord blood mononuclear cells is similar to Langerhans cells of the skin: a study with peanut agglutinin and monoclonal antibodies.
    Gothelf Y; Sharon N; Gazit E
    Hum Immunol; 1986 Feb; 15(2):164-74. PubMed ID: 3949553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionation of human bone-marrow mononuclear cells with peanut agglutinin: phenotypic characterization with monoclonal antibodies.
    Gothelf Y; Sharon N; Gazit E
    Hum Immunol; 1986 Sep; 17(1):37-44. PubMed ID: 3528082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of OKT6-positive cells (without visible Birbeck granules) in normal peripheral blood.
    Dezutter-Dambuyant C; Schmitt D; Faure M; Cordier G; Thivolet J
    Immunol Lett; 1984; 8(3):121-6. PubMed ID: 6437968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy.
    Murphy GF; Bhan AK; Harrist TJ; Mihm MC
    Br J Dermatol; 1983 Apr; 108(4):423-31. PubMed ID: 6687687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics.
    Strobl H; Scheinecker C; Riedl E; Csmarits B; Bello-Fernandez C; Pickl WF; Majdic O; Knapp W
    J Immunol; 1998 Jul; 161(2):740-8. PubMed ID: 9670950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
    Crivellato E; Damiani D; Mallardi F
    Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin ligands on human dendritic cells and identification of a peanut agglutinin positive subset in blood.
    El Sherbini H; Hock B; Fearnley D; McLellan A; Vuckovic S; Hart DN
    Cell Immunol; 2000 Feb; 200(1):36-44. PubMed ID: 10716881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do circulating OKT6-reactive cells belong to Langerhans cell lineage?
    Dezutter-Dambuyant C; Schmitt D; Thivolet J
    Thymus; 1988; 11(4):207-19. PubMed ID: 3051539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR+/T6- Langerhans cells of the human cornea.
    Seto SK; Gillette TE; Chandler JW
    Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1719-22. PubMed ID: 3498703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immature T lymphocytes after injury characterized by morphology and phenotypic markers.
    Wood JJ; O'Mahony JB; Rodrick ML; Mannick JA
    Ann Surg; 1987 Nov; 206(5):564-71. PubMed ID: 2445312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
    Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
    Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M
    J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin.
    Cruchley AT; Speight PM; Williams DM
    Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
    Ashworth J; Kahan MC; Breathnach SM
    J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.